Additionally, both CB1 and CB2 cannabinoid receptors in the AD brain are nitrosylated, and this could contribute to the impaired coupling of these receptors to downstream effector signaling molecules (Ramírez et al., 2005). This evidence concerns the gene CNR2 and Alzheimer disease.